Search Results for: covid-19
Taconic Biosciences Launches Critical Model for COVID-19 Research October 29, 2020Taconic Biosciences recently announced immediate humanized ACE2 mouse model availability for COVID-19 research. The SARS-CoV-2 virus, which causes COVID-19, uses...
Hovione Announces Partnership to Produce Ligand’s Captisol; Used in Gilead’s Covid-19 Treatment September 23, 2020
Hovione recently announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol, a Ligand product, which is a chemically modified cyclodextrin proven to improve the solubility….
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine September 15, 2020Vaxart, Inc. recently announced the US FDA has completed its review of the company’s Investigational New Drug (IND) application for...
AnGes & Brickell Biotech Announce Collaboration Agreement for the Development of a Novel DNA Vaccine Candidate for COVID-19 September 9, 2020
AnGes, Inc. recently announced a collaboration agreement with Brickell Biotech, Inc. through which Brickell has the right to develop AnGes’ proprietary….
SGS Enrolls First Patient Into Biophytis COVA Clinical Study, a COVID-19 Related Acute Respiratory Failure Treatment Clinical Trial September 3, 2020
SGS recently announce the enrollment of the first patient into an important new clinical trial designed to examine the safety, tolerability, and efficacy of….
First Patient Dosed in AstraZeneca’s Phase 3 COVID-19 Vaccine Trial September 2, 2020Headlands Research is pleased to announce that on Friday, Aug. 28, its JEM Research Institute clinical trial site in Lake...
Contributor Cindy H. Dubin interviews several leading companies and highlights trends in autoinjectors, pen injectors, wearable devices and connectivity, and prefilled syringes.
Catalent Signs Agreement With AstraZeneca to Expand Manufacturing Support for COVID-19 Vaccine August 26, 2020
Catalent, Inc. recently announced that Catalent Cell & Gene Therapy will provide drug substance manufacturing to AstraZeneca for the University of Oxford’s adenovirus vector-based COVID-19 vaccine….
Ingenza Meets a key Milestone in the Deployment of Novel Cost-Effective COVID-19 Vaccine Technology August 20, 2020
Edinburgh-based biotech company Ingenza Ltd. has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current COVID-19 pandemic…..